Document is current
Any future updates will be listed below
-
Authors
Rechtzigel, Mitchell J. https://orcid.org/0000-0002-5298-7391
Lee, Brittany
Neville, Christine https://orcid.org/0009-0000-1762-0423
Huang, Ting https://orcid.org/0000-0003-1041-2167
Díaz, Ramón
Campos, Alex Rosa https://orcid.org/0000-0003-3988-7764
Motamedchaboki, Khatereh
Hornburg, Daniel https://orcid.org/0000-0002-6618-7774
Johnson, Tyler B.
Swier, Vicki J.
Weimer, Jill M. https://orcid.org/0000-0003-2504-4942
Brudvig, Jon J. https://orcid.org/0000-0002-3324-6125
-
Funding
Funding for this research was provided by:
ForeBatten Foundation
- License Information
-
More Information
Article History
Received: 13 September 2024
Accepted: 28 October 2025
First Online: 3 March 2026
Competing interests
: The authors declare the following competing interests: J.M.W., J.J.B., T.B.J., and C.N. are employed by Amicus Therapeutics, Inc. and hold equity in the company in the form of stock-based compensation. T.H. has a financial interest in Seer. The remaining authors declare no competing financial interests.
